Recherche - Archive ouverte HAL Accéder directement au contenu

Filtrer vos résultats

3 Résultats
Structure : Identifiant HAL de la structure : 481003

PFOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases (RCSM): Final results of the FFCD 1102 phase II trial

J-B. Bachet , O. Lucidarme , C.B. Levache , E. Maillard , J.L. Raoul et al.
the 42nd ESMO Congress (ESMO 2017), Sep 2017, Madrid, Spain. pp.505P, ⟨10.1093/annonc/mdx393.031⟩
Communication dans un congrès hal-01632415v1
Image document

Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial

T. Aparicio , O. Bouché , P. L. Etienne , E. Barbier , L. Mineur et al.
Digestive and Liver Disease, 2022, pp.S1590-8658(22)00662-4. ⟨10.1016/j.dld.2022.08.036⟩
Article dans une revue inserm-03986083v1

FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial

J.B. Bachet , O. Lucidarme , C.B. Levache , E. Barbier , J.L. Raoul et al.
European Journal of Cancer, 2018, 104, pp.108-116. ⟨10.1016/j.ejca.2018.09.006⟩
Article dans une revue hal-01960176v1